Table 3.
Estimated Quantity of Foreign Protein Produced by a Given Production Systema
System |
Vol. of medium in system |
Total cells in system (vol. × conc.) |
Total product in systemb |
---|---|---|---|
Batch T‐flask (T‐175): |
|||
175 cm2 attached growth in DMEM/F12/10% serumc |
75 ml |
1.8 × 107 |
0.5‐1 mg |
Batch shake flask (250 ml), 0.5‐1% serumc |
100 ml |
2 × 108 |
2‐4 mg |
Batch 5‐liter spinner flaskc |
1000 ml |
1 × 109 |
10‐20 mg |
Batch 5‐liter spinner flask fitted with O2 frit spargerc |
1000 ml |
2 × 109 |
20‐40 mg |
Batch 15‐liter bioreactor with pH and O2 controlc |
10 liters |
2 × 1010 |
200‐400 mg |
Continuous‐mode 15‐liter perfusion reactor with pH and O2 control and cell retention |
5‐20 liter perfusion per day |
1 × 1011 |
100‐400 mg per day |
Quantities assume a specific productivity of 1 to 4 mg/109 viable cells per day.
Production of recombinant intracellular protein may achieve ∼0.1% of total cell protein.
Batch culture would be performed for 4 days after inoculation of 1 × 105 viable cells/ml.
This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.